| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 600757 | 68124 | CEFTAZIDIMA LDP TORLAN 1.000 mg polvo y disolvente para solución inyectable EFG | CEFTAZIDIMA LDP TORLAN 1.000 mg polvo y disolvente para solución inyectable EFG , 50 viales + 50 ampollas de disolvente | 1.000 mg | 45 | 50 | 34 | 50 viales + 50 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68124/68124_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68124/68124_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1626 | LDP LABORATORIOS TORLAN S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2011-02-28 | 1 | 2012-10-18 | View Edit Delete | ||||||||||||
| 607514 | 68122 | CEFTAZIDIMA LDP TORLAN 2 G POLVO PARA SOLUCION PARA PERFUSION EFG | CEFTAZIDIMA LDP TORLAN 2 G POLVO PARA SOLUCION PARA PERFUSION EFG, 10 viales | 2.000 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68122/68122_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68122/68122_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1626 | LAPHYSAN S.A.U. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2022-07-05 | 1 | 2022-10-24 | View Edit Delete | ||||||||||||
| 656266 | 68117 | METAMIZOL ALTER 575 mg CAPSULAS EFG | METAMIZOL ALTER 575 mg CAPSULAS EFG , 10 cápsulas | 575 mg | 5 | 10 | 43 | 10 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68117/68117_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68117/68117_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2006-10-30 | 0 | 2015-07-16 | View Edit Delete | ||||||||||||
| 656267 | 68117 | METAMIZOL ALTER 575 mg CAPSULAS EFG | METAMIZOL ALTER 575 mg CAPSULAS EFG , 20 cápsulas | 575 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68117/68117_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68117/68117_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2006-10-30 | 0 | 2015-07-16 | View Edit Delete | ||||||||||||
| 656262 | 68116 | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG, 10 cápsulas | 575 mg | 5 | 10 | 43 | 10 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68116/68116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68116/68116_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2006-10-30 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656263 | 68116 | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG, 20 cápsulas | 575 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68116/68116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68116/68116_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2006-10-30 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 694023 | 68114 | CEFUROXIMA NORMON 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CEFUROXIMA NORMON 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 10 comprimidos | 250 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68114/68114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68114/68114_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2012-10-22 | 1 | 2013-05-28 | View Edit Delete | ||||||||||||
| 694024 | 68114 | CEFUROXIMA NORMON 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CEFUROXIMA NORMON 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 15 comprimidos | 250 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68114/68114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68114/68114_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2012-10-22 | 1 | 2013-05-28 | View Edit Delete | ||||||||||||
| 694025 | 68114 | CEFUROXIMA NORMON 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CEFUROXIMA NORMON 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 250 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68114/68114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68114/68114_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2012-10-22 | 1 | 2013-05-28 | View Edit Delete | ||||||||||||
| 694027 | 68115 | CEFUROXIMA NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CEFUROXIMA NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 10 comprimidos | 500 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68115/68115_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68115/68115_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2012-10-22 | 1 | 2013-05-29 | View Edit Delete | ||||||||||||
| 694028 | 68115 | CEFUROXIMA NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CEFUROXIMA NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 15 comprimidos | 500 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68115/68115_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68115/68115_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2012-10-22 | 1 | 2013-05-31 | View Edit Delete | ||||||||||||
| 694029 | 68115 | CEFUROXIMA NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CEFUROXIMA NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 20 comprimidos | 500 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68115/68115_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68115/68115_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2012-10-22 | 1 | 2013-06-06 | View Edit Delete | ||||||||||||
| 656290 | 68128 | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68128/68128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68128/68128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2006-11-02 | 1 | 1 | 1 | 2006-11-02 | 2006-11-02 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656284 | 68125 | MOVIPREP POLVO PARA SOLUCION ORAL | MOVIPREP POLVO PARA SOLUCION ORAL , 2 sobres de 112 g + 2 sobres de 11 g | N/A (más de 4 PA) | 35 | 1 | 17 | 2 sobres de 112 g + 2 sobres de 11 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68125/68125_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68125/68125_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30058 | NORGINE DE ESPANA S.L.U. | 2006-11-02 | 1 | 1 | 1 | 2006-11-02 | 2006-11-02 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 656295 | 68132 | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 14 cápsulas | 40 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68132/68132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68132/68132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2006-11-03 | 1 | 1 | 1 | 2006-11-03 | 2006-11-03 | 1 | 2018-06-19 | View Edit Delete | ||||||||||||
| 656296 | 68132 | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES, 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68132/68132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68132/68132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2006-11-03 | 1 | 1 | 1 | 2006-11-03 | 2006-11-03 | 1 | 2018-06-19 | View Edit Delete | ||||||||||||
| 723754 | 68132 | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES | DOLINTOL 40 mg CAPSULAS DURAS GASTRORRESISTENTES,56 cápsulas | 40 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68132/68132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68132/68132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15730 | ABABOR PHARMACEUTICALS S.L. | 2006-11-03 | 1 | 1 | 1 | 2006-11-03 | 2018-10-02 | 1 | 2019-10-31 | View Edit Delete | ||||||||||||
| 605787 | 68095 | CIPROFLOXACINO KABI 2 MG/ML SOLUCION PARA PERFUSION EFG | CIPROFLOXACINO KABI 2 MG/ML SOLUCION PARA PERFUSION EFG, 20 x 200 ml | 400 mg | 6 | 20 | 48 | 20 x 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68095/68095_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68095/68095_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2006-11-06 | 1 | 1 | 1 | 2006-11-06 | 2006-11-06 | 1 | 2016-10-05 | View Edit Delete | ||||||||||||
| 607128 | 68095 | CIPROFLOXACINO KABI 2 MG/ML SOLUCION PARA PERFUSION EFG | CIPROFLOXACINO KABI 2 MG/ML SOLUCION PARA PERFUSION EFG, 20 x 100 ml | 200 mg | 6 | 20 | 48 | 20 x 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68095/68095_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68095/68095_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2006-11-06 | 1 | 1 | 1 | 2006-11-06 | 2019-01-22 | 1 | 2019-07-30 | View Edit Delete | ||||||||||||
| 656303 | 68136 | ACETILCISTEINA PENSA 200 mg COMPRIMIDOS EFERVESCENTES EFG | ACETILCISTEINA PENSA 200 mg COMPRIMIDOS EFERVESCENTES EFG, 30 comprimidos | 200 mg | 44 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68136/68136_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68136/68136_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2006-11-06 | 1 | 1 | 1 | 2006-11-06 | 2006-11-06 | 1 | 2011-06-16 | View Edit Delete |
Page 299 of 1036, showing 20 records out of 20703 total, starting on record 5961, ending on 5980